References
- Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47:127-41. https://doi.org/10.4143/crt.2015.060
- Kopelson G, Galdabini J, Warshaw AL, Gunderson LL. Patterns of failure after curative surgery for extra-hepatic biliary tract carcinoma: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1981;7:413-7. https://doi.org/10.1016/0360-3016(81)90118-8
- Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 2003;98:1689-700. https://doi.org/10.1002/cncr.11699
- Koo TR, Eom KY, Kim IA, et al. Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy. Radiat Oncol J 2014;32:63-9. https://doi.org/10.3857/roj.2014.32.2.63
- Gazzaniga GM, Filauro M, Bagarolo C, Mori L. Surgery for hilar cholangiocarcinoma: an Italian experience. J Hepatobiliary Pancreat Surg 2000;7:122-7. https://doi.org/10.1007/s005340050165
- Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463-73. https://doi.org/10.1097/00000658-199610000-00005
- Gwak HK, Kim WC, Kim HJ, Park JH. Extrahepatic bile duct cancers: surgery alone versus surgery plus postoperative radiation therapy. Int J Radiat Oncol Biol Phys 2010;78:194-8. https://doi.org/10.1016/j.ijrobp.2009.07.003
- Jang JY, Kim SW, Park DJ, et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg 2005;241:77-84.
- Borghero Y, Crane CH, Szklaruk J, et al. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol 2008;15:3147-56. https://doi.org/10.1245/s10434-008-9998-7
- Kim K, Chie EK, Jang JY, et al. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience. Am J Clin Oncol 2012;35:136-40. https://doi.org/10.1097/COC.0b013e318209aa29
- Lillemoe KD, Cameron JL. Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach. J Hepatobiliary Pancreat Surg 2000;7:115-21. https://doi.org/10.1007/s005340050164
- Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-17. https://doi.org/10.1097/00000658-200110000-00010
- Nakeeb A, Tran KQ, Black MJ, et al. Improved survival in resected biliary malignancies. Surgery 2002;132:555-63. https://doi.org/10.1067/msy.2002.127555
- Park JH, Choi EK, Ahn SD, et al. Postoperative chemoradiotherapy for extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 2011;79:696-704. https://doi.org/10.1016/j.ijrobp.2009.12.031
- Kim S, Kim SW, Bang YJ, Heo DS, Ha SW. Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 2002;54:414-9. https://doi.org/10.1016/S0360-3016(02)02952-8
- Stein DE, Heron DE, Rosato EL, Anne PR, Topham AK. Positive microscopic margins alter outcome in lymph node-negative cholangiocarcinoma when resection is combined with adjuvant radiotherapy. Am J Clin Oncol 2005;28:21-3. https://doi.org/10.1097/01.coc.0000139017.90599.f5
- Horgan AM, Amir E, Walter T, Knox JJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol 2012;30:1934-40. https://doi.org/10.1200/JCO.2011.40.5381
- Matsuda T, Fujita H, Harada N, et al. Impact of adjuvant radiation therapy for microscopic residual tumor after resection of extrahepatic bile duct cancer. Am J Clin Oncol 2013;36:461-5. https://doi.org/10.1097/COC.0b013e31825494ab
- Nelson JW, Ghafoori AP, Willett CG, et al. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 2009;73:148-53. https://doi.org/10.1016/j.ijrobp.2008.07.008
- Ben-Josef E, Guthrie KA, El-Khoueiry AB, et al. SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol 2015;33:2617-22. https://doi.org/10.1200/JCO.2014.60.2219
- National Comprehensive Cancer Network. Hepatobiliary cancer (version 2. 2016) [Internet]. Fort Washington, PA: National Comprehensive Cancer Network; c2016 [cited 2016 Oct 24]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf.
Cited by
- Role of adjuvant radiotherapy for localized extrahepatic bile duct cancer vol.90, pp.1071, 2016, https://doi.org/10.1259/bjr.20160807
- Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution vol.8, pp.44, 2016, https://doi.org/10.18632/oncotarget.17368
- Salvage radiotherapy for locoregionally recurrent extrahepatic bile duct cancer after radical surgery vol.90, pp.1080, 2017, https://doi.org/10.1259/bjr.20170308
- Patterns of initial failure after resection for gallbladder cancer: implications for adjuvant radiotherapy vol.35, pp.4, 2017, https://doi.org/10.3857/roj.2017.00388
- Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma vol.20, pp.8, 2016, https://doi.org/10.1007/s12094-017-1815-y
- The impact of perioperative CA19‐9 change on the survival and recurrence patterns after adjuvant chemoradiotherapy in resectable extrahepatic cholangiocarcinoma vol.117, pp.3, 2016, https://doi.org/10.1002/jso.24856
- High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer patients vol.44, pp.5, 2016, https://doi.org/10.1016/j.ejso.2018.01.012
- Risk factors associated with locoregional failure and estimation of survival after curative resection for patients with distal bile duct cancer vol.9, pp.None, 2016, https://doi.org/10.1038/s41598-019-41622-2
- Radiation therapy for extrahepatic bile duct cancer: Current evidences and future perspectives vol.7, pp.11, 2019, https://doi.org/10.12998/wjcc.v7.i11.1242
- Retrospective analysis of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy of postoperative treatment for biliary tract cancer vol.37, pp.4, 2019, https://doi.org/10.3857/roj.2019.00430
- Is it necessary to receive radiation for pT3‐4N0 oral cancer without other adverse risk features? vol.26, pp.6, 2016, https://doi.org/10.1111/odi.13336